StockData
CVRx, Inc. logo

CVRx, Inc. (CVRX) stock

CVRXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3091% below fair value
$0.60−0.01 (-1.15%)

Close on Nov 18, 2026Market cap $16.09MP/E –Yield –

CVRx net income

Net income is the profit left for shareholders after every expense, interest and tax.

CVRx's net income for the twelve months ending Jun 30, 2026 was -$51.97M. For fiscal 2025 it was -$53.31M. The highest annual figure on record is -$14.11M in fiscal 2020.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$53.31M–
FY2024Dec 31, 2024-$59.97M–
FY2023Dec 31, 2023-$41.20M–
FY2022Dec 31, 2022-$41.43M–
FY2021Dec 31, 2021-$43.08M–
FY2020Dec 31, 2020-$14.11M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$14.04M–
Q1 FY2026Mar 31, 2026-$13.12M–
Q4 FY2025Dec 31, 2025-$11.93M–
Q3 FY2025Sep 30, 2025-$12.87M–
Q2 FY2025Jun 30, 2025-$14.74M–
Q1 FY2025Mar 31, 2025-$13.77M–
Q4 FY2024Dec 31, 2024-$10.65M–
Q3 FY2024Sep 30, 2024-$13.10M–
Q2 FY2024Jun 30, 2024-$14.03M–
Q1 FY2024Mar 31, 2024-$22.19M–
Q4 FY2023Dec 31, 2023-$9.16M–
Q3 FY2023Sep 30, 2023-$9.01M–
Q2 FY2023Jun 30, 2023-$11.65M–
Q1 FY2023Mar 31, 2023-$11.37M–
Q4 FY2022Dec 31, 2022-$10.54M–
Q3 FY2022Sep 30, 2022-$9.83M–
Q2 FY2022Jun 30, 2022-$11.07M–
Q1 FY2022Mar 31, 2022-$9.99M–
Q4 FY2021Dec 31, 2021-$10.57M–
Q3 FY2021Sep 30, 2021-$6.13M–
Q2 FY2021Jun 30, 2021-$17.75M–
Q1 FY2021Mar 31, 2021-$8.63M–
Q4 FY2020Dec 31, 2020-$3.40M–
Q3 FY2020Sep 30, 2020-$3.23M–
Q2 FY2020Jun 30, 2020-$3.67M–

More CVRx figures

See a number that looks wrong?